PRODUCT

首頁

產品資訊

PRODUCT

首頁

產品資訊

Cambridge 劍橋 CANTAB 測驗 - DMS 樣本延遲配對測驗

產品型號: DMS
廠牌名稱: Cambridge Cognition
樣本延遲配對測驗 (Delayed Matching to Sample)
CANTAB 劍橋認知心理衡鑑系統中的視覺記憶測驗之一

產品特點

  • 簡介:樣本延遲配對 (DMS) 是在衡鑑口語無法描述的新穎圖案之強迫選擇的再認記憶,會測驗視覺記憶和短期視覺記憶。這個測驗主要是對內側額葉區域損傷患者的前額葉訊號輸入非常敏感。
  • 施測時間:大約 10 分鐘。
  • 作業:螢幕上顯示一個複雜的圖案 (樣本圖),過了一小段時間後,會出現 4 個相似的圖案。受測者需要觸碰與樣本圖完全相同的那個圖案。
  • 測驗結果:本測驗會有 19 個結果,頻估延遲時間 (受測者的反應速度)、選擇正確圖案的次數、正確或錯誤反應後下個試驗錯誤率的統計分析…等。


CANTAB Connect Research 劍橋神經認知測驗介紹

產品規格

主要參考文獻

Cantab Depression Battery
• Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2013 Oct 29:1-12. [Epub ahead of print]
• Roiser JP, Sahakian BJ. Hot and cold cognition in depression. CNS Spectr. 2013 Jun;18(3):139-49.
• Egerházi A, Balla P, Ritzl A, Varga Z, Frecska E, Berecz R. Automated Neuropsychological Test Battery in depression -- preliminary data. Neuropsychopharmacol Hung. 2013 Mar;15(1):5-11.
• Greer TL, Sunderajan P, Grannemann BD, Kurian BT, Trivedi MH. Does duloxetine improve cognitive function independently of its antidepressant effect in patients with major depressive disorder and subjective reports of cognitive dysfunction? Depress Res Treat. 2014;2014:627863.
• van Tol MJ, van der Wee NJ, Demenescu LR, Nielen MM, Aleman A, Renken R, van Buchem MA, Zitman FG, Veltman DJ. Functional MRI correlates of visuospatial planning in out-patient depression and anxiety. Acta Psychiatr Scand. 2011 Oct;124(4):273-84.
• Papakostas GI. Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice. J Clin Psychiatry. 2014 Jan;75(1):8-14.
- 更多資訊請見: http://www.cambridgecognition.com/academic-studies/product/cantab-depression-battery#sthash.DbwguDPJ.HoD2Vjyp.dpuf

Cantab Alzheimer’s (Dementia) Battery
• Fowler KS, Saling MM, Conway EL, Semple JM, Louis WJ. Paired associate performance in the early detection of DAT. Journal of the International Neuropsychological Society : JINS. 2002;8(1):58-71.
• Egerhazi A, Berecz R, Bartok E, Degrell I. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer’s disease. Progress in neuro-psychopharmacology & biological psychiatry. 2007;31(3):746-51. Epub 2007/02/10.
• Blackwell AD, Sahakian BJ, Vesey R, Semple JM, Robbins TW, Hodges JR. Detecting dementia: novel neuropsychological markers of preclinical Alzheimer’s disease. Dement Geriatr Cogn Disord. 2004;17(1-2):42-8. Epub 2003 Oct 13.
• Greig NH, Sambamurti K, Yu QS, Brossi A, Bruinsma GB, Lahiri DK. An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer’s disease. Curr Alzheimer Res. 2005;2(3):281-90.
• Atack JR. Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA. Pharmacology & therapeutics. 2010;125(1):11-26. Epub 2009/09/23.
- 更多資訊請見: http://www.cambridgecognition.com/academic-studies/product/cantab-dementia-battery#sthash.rL7KE7eu.dpuf

應用領域

用於:CANTAB Alzheimer’s battery 和 CANTAB Depression Battery

詢價表單

填寫完成

您可以繼續瀏覽或轉移至產品列表!

回產品列表